Infectious Disease
From Classic to Cutting-Edge: The Evolution of Vaccine Technologies
This program supports clinicians in discussing the past, present, and future of vaccine innovation. The program provides a foundation on common vaccine types and traditional vaccine development. This is followed by an overview of novel vaccine technologies and their role in known and emerging infectious diseases and diseases not traditionally addressed by vaccination.
DURATION
30 min
PROFESSION
Physician
# OF CREDITS
0.5
ACCREDITATION
Mainpro+
EXPIRY DATE
2024-10-11
Vaccination remains a very effective method of preventing infectious diseases and represents a relevant contribution to human health. An estimated 3 to 5.5 million deaths are averted each year due to vaccination. This program supports clinicians in discussing the past, present, and future of vaccine innovation. The program provides a foundation on common vaccine types and traditional vaccine development. This is followed by an overview of novel vaccine technologies and their role in known and emerging infectious diseases and diseases not traditionally addressed by vaccination.
This program has received an unrestricted educational grant or in-kind support from Moderna Biopharm Canada Inc.
Faculty
Mark Loeb, MSc, MD, FRCPC
Chandi Chandrasena, MD, CCFP, FCFP
Naomi Pliamm, MD, CFPC
Sofia Nastis, MD, CCFP
Learning objectives
Upon completion of this continuing education program, participants will be able to:
- Describe common vaccine types and their functionality
- Compare and contrast the benefits and drawbacks of common vaccine types
- Describe novel vaccine technologies and their potential impact on both infectious and non-infectious disease
Accreditation
This Self-Learning program has been certified by the College of Family Physicians of Canada for up to 0.5 Mainpro+ Credit(s).
Cert+ Program ID#: 200999